XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect, period of adoption, adjustment
Common stock
Additional paid-in capital
Additional paid-in capital
Cumulative effect, period of adoption, adjustment
Accumulated deficit
Accumulated deficit
Cumulative effect, period of adoption, adjustment
Accumulated other comprehensive gain (loss)
Balance (in shares) at Dec. 31, 2021     109,292          
Balance at Dec. 31, 2021 $ 862,396   $ 109 $ 1,298,966   $ (435,227)   $ (1,452)
Increase (Decrease) in Stockholders' Equity                
Net income (loss) (31,198)         (31,198)    
Foreign currency translation adjustment (969)             (969)
Unrealized gain (loss) on marketable securities, net of tax (3,317)             (3,317)
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (in shares)     1,236          
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (12,699)   $ 2 (12,701)        
Stock-based compensation 16,414     16,414        
Issuance of common stock in connection with the payment of Year 1 earn-out related to the PLDA acquisition 0              
Retirement of convertible senior note hedges 62,011     62,011        
Retirement of warrants (46,356)     (46,356)        
Balance (in shares) at Jun. 30, 2022     110,528          
Balance at Jun. 30, 2022 838,158   $ 111 1,283,789   (440,004)   (5,738)
Balance (Accounting Standards Update 2020-06) at Jun. 30, 2022   $ (8,124)     $ (34,545)   $ 26,421  
Balance (in shares) at Mar. 31, 2022     110,235          
Balance at Mar. 31, 2022 793,126   $ 110 1,272,353   (475,024)   (4,313)
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 35,020         35,020    
Foreign currency translation adjustment (676)             (676)
Unrealized gain (loss) on marketable securities, net of tax (749)             (749)
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (in shares)     293          
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan 2,801   $ 1 2,800        
Stock-based compensation 8,636     8,636        
Balance (in shares) at Jun. 30, 2022     110,528          
Balance at Jun. 30, 2022 838,158   $ 111 1,283,789   (440,004)   (5,738)
Balance (Accounting Standards Update 2020-06) at Jun. 30, 2022   $ (8,124)     $ (34,545)   $ 26,421  
Balance (in shares) at Dec. 31, 2022     107,610          
Balance at Dec. 31, 2022 779,297   $ 108 1,297,408   (513,256)   (4,963)
Increase (Decrease) in Stockholders' Equity                
Exercise of the convertible senior note hedges in conjunction with the conversion of convertible senior notes (in shares)     (300)          
Balance (in shares) at Mar. 31, 2023     108,845          
Balance at Mar. 31, 2023 761,729   $ 109 1,286,570   (521,415)   (3,535)
Balance (in shares) at Dec. 31, 2022     107,610          
Balance at Dec. 31, 2022 779,297   $ 108 1,297,408   (513,256)   (4,963)
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 172,161         172,161    
Foreign currency translation adjustment 330             330
Unrealized gain (loss) on marketable securities, net of tax 1,604             1,604
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (in shares)     1,323          
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (26,837)   $ 1 (26,838)        
Stock-based compensation 24,438     24,438        
Issuance of common stock in connection with the payment of Year 1 earn-out related to the PLDA acquisition (in shares)     198          
Issuance of common stock in connection with the payment of Year 1 earn-out related to the PLDA acquisition 5,022     5,022        
Issuance of common stock in connection with the maturity of the convertible senior notes related to the settlement of the in-the-money conversion feature of the convertible senior notes (in shares)     284          
Exercise of the convertible senior note hedges in conjunction with the conversion of convertible senior notes (in shares)     (284)          
Exercise of the convertible senior note hedges in conjunction with the conversion of convertible senior notes       11,440   (11,440)    
Retirement of warrants (10,457)     (10,457)        
Balance (in shares) at Jun. 30, 2023     109,131          
Balance at Jun. 30, 2023 945,558   $ 109 1,301,013   (352,535)   (3,029)
Balance (in shares) at Mar. 31, 2023     108,845          
Balance at Mar. 31, 2023 761,729   $ 109 1,286,570   (521,415)   (3,535)
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 168,880         168,880    
Foreign currency translation adjustment 125             125
Unrealized gain (loss) on marketable securities, net of tax 381             381
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan (in shares)     286          
Issuance of common stock upon exercise of options, equity stock and employee stock purchase plan 3,068     3,068        
Stock-based compensation 11,375     11,375        
Balance (in shares) at Jun. 30, 2023     109,131          
Balance at Jun. 30, 2023 $ 945,558   $ 109 $ 1,301,013   $ (352,535)   $ (3,029)